European Journal of Medicinal Chemistry p. 1135 - 1146 (2017)
Update date:2022-08-29
Topics:
Yuan, Zigao
Chen, Shaopeng
Chen, Changjun
Chen, Jiwei
Chen, Chengken
Dai, Qiuzi
Gao, Chunmei
Jiang, Yuyang
PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.
View MoreContact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
ZhangJiaGang YaRui Chemical Co.,Ltd.
Contact:0512-58360968
Address:China JiangSu Province Zhang Jia Gang City YangShe Oriental Plaza Building 10 B307
NINGXIA DARONG CHEMICALS & METALLURGY CO.,LTD.
Contact:86-952-2179751
Address:Darong Road, Dawukou, Shizuishan, Ningxia 753001, China
Shenzhen Hongyuan Import & Export Co., Ltd.
Contact:0755-26407171
Address:Shenzhen Hongyuan Chemical New Materials Technology Co., Ltd.
Doi:10.1080/00397911.2010.519848
(2011)Doi:10.1002/(SICI)1097-4601(1996)28:11<799::AID-KIN2>3.0.CO;2-I
(1996)Doi:10.1039/b922450e
(2010)Doi:10.1016/0022-4596(92)90048-Z
(1992)Doi:10.1016/j.cattod.2018.07.033
(2019)Doi:10.1093/geronb/57.2.P144
(1902)